Stock image Immunoreceptor
Engineered Receptors (light Blue) On The Surface Of A T-lymphocyte Bind Specifically To CD19-antigen Molecules (magenta) On A Leukemia Cell. This Activates A Signal Cascade In The T-cell Leading To The Apoptosis Of The Cancer Cell.
Image, 11.66MB, 8000 × 6000 jpg
T-cell Receptors Are Similar To One Arm Of An Antibody. Like Antibodies, They Are Composed Of Two Chains. The Binding Site Is At The Tip Of The Molecule,
Image, 2.5MB, 8000 × 6000 jpg
CAR T-cell Therapy. Cancer Immunotherapy. Killing Of Tumor Cells. Genetically Engineered. Personalized Medicine. Vector Poster. Isometric Flat Illustration.
Vector, 8.37MB, 11801 × 8257 eps
Engineered Receptors (light Blue) On The Surface Of A T-lymphocyte Bind Specifically To CD19-antigen Molecules (magenta) On A Leukemia Cell. This Activates A Signal Cascade In The T-cell Leading To The Segregation Of Vesicles That Contain Perforin An
Image, 11.44MB, 8000 × 6000 jpg
3d Computer Illustration Of A Chimeric Antigen Receptor. CARs Are Engineered Cell Receptors That Allow T Cells To Recognize And Attack Cancer Cells In A Specific Way. They Are Built By Connecting Several Functional Parts From Different Proteins.
Image, 8.45MB, 8000 × 6000 jpg
CAR - Chimeric Antigen Receptor T Cell. Lymphocyte That Have Been Genetically Engineered To Produce An Artificial T-cell Receptor For Use In Immunotherapy. Treatment Of Cancer. Vector Illustration
Vector, 6.18MB, 5000 × 3443 eps
3d Computer Illustration Of A Chimeric Antigen Receptor. CARs Are Engineered Cell Receptors That Allow T Cells To Recognize/attack Specifically Cancer Cells. A Signal Protein Is Attached To The Intracellular Domain.
Image, 2.19MB, 8000 × 6000 jpg
3d Computer Illustration Of A Chimeric Antigen Receptor. CARs Are Engineered Cell Receptors That Allow T Cells To Recognize/attack Specifically Cancer Cells. A Signal Protein Is Attached To The Intracellular Domain.
Image, 3.45MB, 8000 × 6000 jpg
Page 1 >> Next